Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025
Nanox (NASDAQ:NNOX), a medical imaging technology company, has scheduled its second quarter 2025 financial results announcement for August 12, 2025, before market open.
The company will host a conference call at 8:30 a.m. ET featuring CEO and Acting Chairman Erez Meltzer and CFO Ran Daniel, who will review the results and provide a business update. Investors can access the presentation through a live webcast available on the company's Investor Relations website.
Nanox (NASDAQ:NNOX), un'azienda specializzata in tecnologia per l'imaging medico, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per il 12 agosto 2025, prima dell'apertura dei mercati.
L'azienda terrà una conference call alle 8:30 a.m. ET con la partecipazione del CEO e Presidente ad interim Erez Meltzer e del CFO Ran Daniel, che presenteranno i risultati e forniranno un aggiornamento sulle attività aziendali. Gli investitori potranno seguire la presentazione tramite una diretta web accessibile dal sito web della sezione Investor Relations della società.
Nanox (NASDAQ:NNOX), una empresa de tecnología en imágenes médicas, ha programado el anuncio de sus resultados financieros del segundo trimestre de 2025 para el 12 de agosto de 2025, antes de la apertura del mercado.
La compañía realizará una llamada conferencia a las 8:30 a.m. ET con el CEO y Presidente Interino Erez Meltzer y el CFO Ran Daniel, quienes revisarán los resultados y ofrecerán una actualización comercial. Los inversores podrán acceder a la presentación mediante una transmisión en vivo disponible en el sitio web de Relaciones con Inversores de la empresa.
Nanox (NASDAQ:NNOX)는 의료 영상 기술 회사로서 2025년 2분기 재무 실적 발표를 2025년 8월 12일 시장 개장 전으로 예정했습니다.
회사는 CEO 겸 임시 의장인 에레즈 멜처(Erez Meltzer)와 CFO 란 다니엘(Ran Daniel)이 참여하는 컨퍼런스 콜을 동부 시간 기준 오전 8시 30분에 개최하여 실적을 검토하고 사업 현황을 업데이트할 예정입니다. 투자자들은 회사의 투자자 관계 웹사이트에서 실시간 웹캐스트를 통해 프레젠테이션에 접속할 수 있습니다.
Nanox (NASDAQ:NNOX), une entreprise spécialisée dans la technologie d'imagerie médicale, a prévu d'annoncer ses résultats financiers du deuxième trimestre 2025 le 12 août 2025, avant l'ouverture des marchés.
L'entreprise organisera une conférence téléphonique à 8h30 ET avec le PDG et président par intérim Erez Meltzer ainsi que le directeur financier Ran Daniel, qui présenteront les résultats et fourniront une mise à jour commerciale. Les investisseurs pourront accéder à la présentation via un webcast en direct disponible sur le site des relations investisseurs de la société.
Nanox (NASDAQ:NNOX), ein Unternehmen für medizinische Bildgebungstechnologie, hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 12. August 2025 vor Börsenöffnung geplant.
Das Unternehmen wird um 8:30 Uhr ET eine Telefonkonferenz mit CEO und amtierendem Vorsitzenden Erez Meltzer sowie CFO Ran Daniel abhalten, die die Ergebnisse vorstellen und ein Geschäftsupdate geben werden. Investoren können die Präsentation über einen Live-Webcast auf der Investor-Relations-Website des Unternehmens verfolgen.
- None.
- None.
PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2025, before market open on Tuesday, August 12, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Interested parties may register for the conference call using the following link: Nanox Q2 2025 Conference Call. The live webcast of the conference call may be accessed by using the following link: Nanox Q2 2025 Webcast.
The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.
Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, with an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision.
Contacts
Investor Contact
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Media Contact
ICR Healthcare
NanoxPR@icrinc.com
FAQ
When will Nanox (NNOX) report Q2 2025 earnings?
What time is the Nanox (NNOX) Q2 2025 earnings call?
Who will host the Nanox Q2 2025 earnings call?
How can I access the Nanox Q2 2025 earnings call?
